In one approach, pH-sensitive nanoliposomes were covalently decorated with the SDF1α protein, the natural ligand of CXCR4, to encapsulate and target the marine-derived drug Yessotoxin into CXCR4+ prostate and adenocarcinoma cells [208]. The gene discussed is CXCR4; the disease is adenocarcinoma.